Radiology. 2007 Apr;243(1):132-9. doi: 10.1148/radiol.2431051825. Epub 2007 Feb 28.
To prospectively evaluate the accuracy of magnetic resonance (MR) imaging in depicting the extramural depth of tumor invasion in patients who have rectal cancer, with histopathologic results as the reference standard.
The Magnetic Resonance Imaging and Rectal Cancer European Equivalence (MERCURY) Study received ethics approval from all participating centers, and all patients gave informed consent. Consecutive patients (n = 679) with adenocarcinoma of the rectum consented to participate. Imaging workshops for participating specialist gastrointestinal radiologists were held to ensure standardization of image acquisition techniques. Standardized MR image interpretation and data reporting were performed by using previously validated criteria. MR images were prospectively singly read by the specialist gastrointestinal radiologists. The maximal extramural depth (EMD) of tumor spread, defined at histopathologic analysis as the distance from the outer edge of the longitudinal muscularis propria to the outer edge of the tumor, was measured and recorded. The maximal EMD was the reference standard. The MR and histopathologic results were considered to be equivalent when the 95% confidence interval of the difference between them was within +/-0.5 mm.
Tumor EMD measurements obtained at both MR imaging and histopathologic analysis were available for 295 (95%) of 311 patients after primary surgery. Mean EMDs were 2.80 mm +/- 4.60 (standard deviation) and 2.81 mm +/- 4.28 at MR imaging and histopathologic analysis, respectively. The mean difference between the MR-derived and histopathologically derived EMDs was -0.05 mm +/- 3.85 (95% confidence interval: -0.49 mm, 0.40 mm). Therefore, MR and histopathologic assessments of tumor spread were considered equivalent to within 0.5 mm.
Demonstration of accurate measurement of the depth of extramural tumor spread in the MERCURY Study enabled accurate preoperative prognostication.
以前瞻性方式评估磁共振(MR)成像在描绘直肠癌患者肿瘤壁外浸润深度方面的准确性,以组织病理学结果作为参考标准。
磁共振成像与直肠癌欧洲等效性(MERCURY)研究获得了所有参与中心的伦理批准,所有患者均签署了知情同意书。连续纳入679例直肠腺癌患者并同意参与研究。为参与研究的专科胃肠放射科医生举办了成像研讨会,以确保图像采集技术的标准化。采用先前验证的标准进行标准化的MR图像解读和数据报告。MR图像由专科胃肠放射科医生进行前瞻性单盲解读。测量并记录肿瘤扩散的最大壁外深度(EMD),在组织病理学分析中定义为从固有肌层纵行肌外缘到肿瘤外缘的距离。最大EMD为参考标准。当两者差异的95%置信区间在±0.5 mm内时,认为MR和组织病理学结果等效。
311例患者中,295例(95%)在初次手术后同时获得了MR成像和组织病理学分析的肿瘤EMD测量值。MR成像和组织病理学分析时的平均EMD分别为2.80 mm±4.60(标准差)和2.81 mm±4.28。MR得出的EMD与组织病理学得出的EMD之间的平均差异为-0.05 mm±3.85(95%置信区间:-0.49 mm,0.40 mm)。因此,MR和组织病理学对肿瘤扩散的评估被认为在0.5 mm范围内等效。
MERCURY研究中对肿瘤壁外扩散深度的准确测量证明能够进行准确的术前预后评估。